MRI contrast developer Epix Medical of Cambridge, MA, has set the price for its follow-on public offering of common stock. The company is offering 4.3 million shares at a cost of $15 per share. The shares are being offered from a registration statement covering shares that became effective in January.
SG Cowen and Wells Fargo Securities are co-lead managers of the offering, and will receive an option to purchase an additional 645,000 shares within 30 days to cover any over-allotments incurred in the offering, according to the company.
By AuntMinnie.com staff writersAugust 7, 2003
Related Reading
Epix to offer more shares, July 28, 2003
Epix shows slight revenue increase, lower loss in Q2, July 25, 2003
Epix completes final phase III trials on MRA contrast agent, July 11, 2003
Epix, Schering to partner on MRI contrast, May 27, 2003
Epix revenues gain, losses widen, April 25, 2003
Copyright © 2003 AuntMinnie.com
